In addition, the potential molecular mechanism of CCNA2 affecting ccRCC progression was detected by western blotting, as illustrated in Fig. S5G, the knockdown of CCNA2 inhibited the levels of S-phase related proteins CDK2, thereby affecting cell cycle progression. Here, CDK2 is linked to nonpapillary renal cell carcinoma.